- AU$19.00m
- AU$9.94m
- AU$0.43m
Australia Stock Exchange release from BARD1 LIFE SCI : Results of 2021 Annual General Meeting
Australia's BARD1 Life Sciences jumps on agreement for cancer research
Australia Stock Exchange release from BARD1 LIFE SCI : PRE_NR Ends: 14:03:45
Australia Stock Exchange release from BARD1 LIFE SCI : AGM Presentation
Australia Stock Exchange release from BARD1 LIFE SCI : New BARD1 Exosome Liquid Biopsy Project
Australia Stock Exchange release from BARD1 LIFE SCI : Application for quotation of securities - BD1
Australia Stock Exchange release from BARD1 LIFE SCI : Notification regarding unquoted securities - BD1
Australia Stock Exchange release from BARD1 LIFE SCI : US Patent Issued - BARD1 Patent Family Lung Cancer Diagnosis
Australia Stock Exchange release from BARD1 LIFE SCI : BARD1 Presenting at Bell Potter Healthcare Conference
Australia Stock Exchange release from BARD1 LIFE SCI : EXO-NET ANZSEV Presentation
Australia Stock Exchange release from BARD1 LIFE SCI : EXO-NET Presented at Virtual ANZSEV Symposium
Australia Stock Exchange release from BARD1 LIFE SCI : Jobkeeper Payment Notification
Australia Stock Exchange release from BARD1 LIFE SCI : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from BARD1 LIFE SCI : Ceasing to be a substantial holder
Australia Stock Exchange release from BARD1 LIFE SCI : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from BARD1 LIFE SCI : PRE_NR Ends: 10:27:21
Australia Stock Exchange release from BARD1 LIFE SCI : Appendix 4C & Quarterly Activities Report
Australia Stock Exchange release from BARD1 LIFE SCI : Change of Director's Interest - Philip Powell
Australia Stock Exchange release from BARD1 LIFE SCI : Amended Remuneration Table Directors Report